Partner
Head of Healthcare
Jon Hammack is a Partner and serves as Head of Healthcare, focused on medical devices and outsourced services. He joined the firm in 2021.
Jon has over 20 years of healthcare investment banking experience and specializes in advising clients in the medical device and outsourced services sectors. He has advised boards of directors and special committees as well as companies on a broad range of transactions, including mergers, acquisitions, divestitures, leveraged buyouts, restructurings and capital raising solutions.
Prior to joining Solomon Partners, Jon was a Managing Director at Moelis & Company where he spent eight years leading and expanding the firm’s medical device and outsourced services sectors. Before Moelis, Jon was a Managing Director and Head of Medical Technology at Morgan Stanley.
Over the past two decades, Jon has advised on numerous key healthcare transactions with total transaction value over $100 billion.
Select transactions include:
Jon holds a BS from the University of Washington and an MBA from the Kellogg School of Management at Northwestern University.
Served as financial advisor to Guerbet on the sale of its Accurate Medical microcatheter assets to Argon Medical
Served as financial advisor to Platinum Equity on its acquisition of ASP Global
Served as financial advisor to Prime Therapeutics on its strategic alliance with and minority investment in Capital Rx
Served as financial advisor to TIDI Products on its sale to TJC
Served as financial advisor to Zavation on its acquisition of CoreLink
Served as financial advisor to Vestar Capital on its strategic growth investment in Nox Health
Served as financial advisor to ProSomnus on its merger with Lakeshore Acquisition I SPAC
Served as the exclusive financial advisor and placement agent to Prime Therapeutics on its acquisition of Magellan Rx
Subscribe Episode Description In this episode of Solomon Connects , Solomon Partners’ Head of Healthcare Jon Hammack joins M&A Director Chris Moynihan to unpack the current state of the healthcare M&A market and the key themes shaping a more constructive deal environment this year. Jon shares insights on sponsor and strategic dynamics, record pipelines, improving…
Last month, industry leaders convened in San Francisco for the 44 th annual J.P. Morgan Healthcare Conference. Jon Hammack , Head of Healthcare at Solomon Partners, shared his views on where momentum is building—as well as the challenges remaining—in healthcare M&A heading into 2026. Hammack’s top insights include: 1. M&A Momentum Is Improving—But the Real…
Subscribe Episode Description Solomon’s Head of Healthcare Jon Hammack and Partner Jon Pritti explore the dynamics shaping today’s healthcare M&A market. Healthcare remains a resilient sector despite macroeconomic headwinds and continued interest rate and LP liquidity pressures. They share insights on why momentum is expected to build through late 2025 and into 2026. Transcript Jon…
Head of Healthcare , Jon Hammack sat with CEO Marc Cooper to discuss the latest in the healthcare sector. Click below to watch the full conversation. https://player.vimeo.com/video/836611522
Friends and Colleagues, With another year of M&A and financings in the books, we’re pleased to provide you with our 2022 Year-in-Review. This past year saw a relative return to 2020 levels, after an outlier ’21 in terms of both deal volumes and aggregate value, with ~$14B in disclosed financing proceeds and nearly $70B in…
I recently sat down with Jon Hammack , Managing Director and Head of Healthcare at Solomon Partners. Jon’s been developing our Healthcare business strategy and we talked about his outlook for the healthcare space and recent trends post-pandemic. 1. This July marks your one-year anniversary at Solomon Partners. As you look back, what stands out from…
